US Stock MarketDetailed Quotes
ROIVW ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM)
- 2.7500
- 0.00000.00%
Close Sep 5 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open2.7500Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares4.000052wk High0.00P/B0Float Cap1.720052wk Low--Dividend TTM0Shs Float4.0000Historical High--Div YieldTTM0.00%Amplitude0.2181Historical Low--Avg Price1Lot Size
About ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM) Company
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
Company Profile
SymbolROIVW
Company NameROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM)
CEOMr. Matthew Gline
MarketNASDAQ
Employees904
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Company Executives
- Name
- Position
- Salary
- Matthew Gline
- Chief Executive Officer and Director
- 48.98M
- Richard Pulik
- Chief Financial Officer
- --
- Dr. Mayukh Sukhatme
- Co-President and Chief Investment Officer
- 48.93M
- Dr. Eric Venker, M.D.,Pharm.D.
- Co-President and Chief Operating Officer
- 48.49M
- Rakhi Kumar
- Chief Accounting Officer
- --
- Ilan Oren
- Chairman of the Board
- 403.53K
- Meghan M. Fitzgerald, Ph.
- Independent Director
- 2.34K
- Keith Manchester
- Independent Director
- 391.03K
- James C. Momtazee
- Independent Director
- 394.31K
- Daniel Gold
- Independent Director
- 401.03K
- Melissa B. Epperly
- Independent Director
- 654.02K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg